Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency

Sean J Pittock, Troy A. Payne, C. Michel Harper

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Vitamin B12 deficiency is common, with most patients lacking classic features of advanced severe deficiency. Early diagnosis and treatment prevent severe anemia and irreversible damage to the nervous system. We describe a 34-year-old man with pernicious anemia who presented with clinical and radiologic features of early myelopathy and borderline low serum levels of vitamin B12. Prompt diagnosis based on the measurement of serum methylmalonic acid and treatment with cyanocobalamin injections led to rapid resolution of clinical manifestations and magnetic resonance imaging abnormalities. We review the literature of magnetic resonance imaging in vitamin B12 deficiency myelopathy and discuss the issues relating to diagnosis and early treatment of this potentially reversible condition.

Original languageEnglish (US)
Pages (from-to)291-294
Number of pages4
JournalMayo Clinic Proceedings
Volume77
Issue number3
StatePublished - 2002

Fingerprint

Vitamin B 12 Deficiency
Spinal Cord Diseases
Vitamin B 12
Methylmalonic Acid
Magnetic Resonance Imaging
Pernicious Anemia
Serum
Nervous System
Anemia
Early Diagnosis
Therapeutics
Injections

Keywords

  • MMA = methylmalonic acid
  • MRI = magnetic resonance imaging
  • SCD = subacute combined degeneration

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. / Pittock, Sean J; Payne, Troy A.; Harper, C. Michel.

In: Mayo Clinic Proceedings, Vol. 77, No. 3, 2002, p. 291-294.

Research output: Contribution to journalArticle

Pittock, Sean J ; Payne, Troy A. ; Harper, C. Michel. / Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. In: Mayo Clinic Proceedings. 2002 ; Vol. 77, No. 3. pp. 291-294.
@article{3c5f89c5c93e4f17a5e97ccbd0711fa2,
title = "Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency",
abstract = "Vitamin B12 deficiency is common, with most patients lacking classic features of advanced severe deficiency. Early diagnosis and treatment prevent severe anemia and irreversible damage to the nervous system. We describe a 34-year-old man with pernicious anemia who presented with clinical and radiologic features of early myelopathy and borderline low serum levels of vitamin B12. Prompt diagnosis based on the measurement of serum methylmalonic acid and treatment with cyanocobalamin injections led to rapid resolution of clinical manifestations and magnetic resonance imaging abnormalities. We review the literature of magnetic resonance imaging in vitamin B12 deficiency myelopathy and discuss the issues relating to diagnosis and early treatment of this potentially reversible condition.",
keywords = "MMA = methylmalonic acid, MRI = magnetic resonance imaging, SCD = subacute combined degeneration",
author = "Pittock, {Sean J} and Payne, {Troy A.} and Harper, {C. Michel}",
year = "2002",
language = "English (US)",
volume = "77",
pages = "291--294",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency

AU - Pittock, Sean J

AU - Payne, Troy A.

AU - Harper, C. Michel

PY - 2002

Y1 - 2002

N2 - Vitamin B12 deficiency is common, with most patients lacking classic features of advanced severe deficiency. Early diagnosis and treatment prevent severe anemia and irreversible damage to the nervous system. We describe a 34-year-old man with pernicious anemia who presented with clinical and radiologic features of early myelopathy and borderline low serum levels of vitamin B12. Prompt diagnosis based on the measurement of serum methylmalonic acid and treatment with cyanocobalamin injections led to rapid resolution of clinical manifestations and magnetic resonance imaging abnormalities. We review the literature of magnetic resonance imaging in vitamin B12 deficiency myelopathy and discuss the issues relating to diagnosis and early treatment of this potentially reversible condition.

AB - Vitamin B12 deficiency is common, with most patients lacking classic features of advanced severe deficiency. Early diagnosis and treatment prevent severe anemia and irreversible damage to the nervous system. We describe a 34-year-old man with pernicious anemia who presented with clinical and radiologic features of early myelopathy and borderline low serum levels of vitamin B12. Prompt diagnosis based on the measurement of serum methylmalonic acid and treatment with cyanocobalamin injections led to rapid resolution of clinical manifestations and magnetic resonance imaging abnormalities. We review the literature of magnetic resonance imaging in vitamin B12 deficiency myelopathy and discuss the issues relating to diagnosis and early treatment of this potentially reversible condition.

KW - MMA = methylmalonic acid

KW - MRI = magnetic resonance imaging

KW - SCD = subacute combined degeneration

UR - http://www.scopus.com/inward/record.url?scp=0036183572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036183572&partnerID=8YFLogxK

M3 - Article

C2 - 11888035

AN - SCOPUS:0036183572

VL - 77

SP - 291

EP - 294

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -